Journals
Publish with us
Publishing partnerships
About us
Blog
Journal of Oncology
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Journal of Oncology
/
2022
/
Article
/
Tab 1
/
Research Article
Clinical Efficacy of PD-1 Inhibitors Plus Split-Course Radiotherapy in the First-Line Treatment of Advanced Kidney Cancer: A Randomized Controlled Trial
Table 1
Baseline demographics and clinical characteristics.
Control group (
n
= 22)
Study group (
n
= 22)
t/
χ
2
Age (
,
years)
62.34 ± 15.67
60.94 ± 13.67
0.316
0.754
Gender (
n
)
0.820
0.183
Male
12
9
Female
10
13
KPS scores
0.702
0.873
70
3
4
80
6
6
90
8
9
100
5
3
Evaluable disease sites
0.611
0.434
1
3
5
≥2
19
17
Histology (
n
)
0.140
0.709
Squamous
4
5
Nonsquamous
18
17
Brain metastasis (
n
)
0.518
0.472
Yes
4
6
No
18
16
Stage (
n
)
0.393
0.531
III
7
9
IV
15
13
ECOG score (
n
)
0.367
0.545
1
9
11
2
13
11